2025-03-31 19:44:27
Latest Post
NHPC commissions 3 units of Parbati-II HE project
ixigo announces APRIL FULL REFUND SALE for 1st April - 100 Lucky Travellers To Win 100% Refund on Flight Bookings
Engineers India Ltd receives orders worth Rs. 245 crores
Blue Star appoints Mohit Sud as Group President, Unitary Cooling Products 
Jyoti Ltd receives Rs. 108.17 crores IT demand notice for AY 2020-21
Stock Report
Gujarat Themis Biosyn Q3FY22 profit lower at Rs. 7.12 crores
Posted On : 2022-02-11 13:59:11( TIMEZONE : IST )
GUJARAT THEMIS BIOSYN LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 19.2968 crores during the period ended December 31, 2021 as compared to Rs. 35.7613 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 7.1206 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 13.7920 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 4.90 for the period ended December 31, 2021 as compared to Rs. 9.49 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 19.2968 crs | ₹35.7613 crs |  -46.04% |
| Net Profit | ₹7.1206 crs | ₹13.7920 crs | -48.37% |
| EPS | ₹4.90 | ₹9.49 | -48.37% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 19.2968 crores during the period ended December 31, 2021 as compared to Rs.25.0640 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.7.1206 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.7.4702 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.4.90 for the period ended December 31, 2021 as compared to Rs.5.14 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 19.2968 crs | ₹25.0640 crs | -23.01% |
| Net Profit | ₹7.1206 crs | ₹7.4702 crs | -4.68% |
| EPS | ₹4.90 | ₹5.14 | -4.67% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.88.6316 crores during the 9 Months period ended December 31, 2021 as compared to Rs.69.7355 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.33.8353 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.24.3889 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.23.29 for the 9 Months period ended December 31, 2021 as compared to Rs.16.79 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹88.6316 crs | ₹69.7355 crs |  27.10% |
| Net Profit | ₹33.8353 crs | ₹24.3889 crs | 38.73% |
| EPS | ₹23.29 | ₹16.79 | 38.71% |
Shares of GUJARAT THEMIS BIOSYN LTD. was last trading in BSE at Rs. 419.80 as compared to the previous close of Rs. 406.50. The total number of shares traded during the day was 16431 in over 466 trades.
The stock hit an intraday high of Rs. 421.00 and intraday low of 395.00. The net turnover during the day was Rs. 6648352.00.
